Annual report
6095.TEDINET S100PT7O
Period2021-10-01 → 2022-09-30
Filed2022-12-15
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥7.4bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2017-10-01 → 2018-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥555m | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥379m | 2017-10-01 → 2018-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.1bn | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥812m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥726m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥395m | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥206m | 2017-10-01 → 2018-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥815m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥9.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥7.1bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥4.0bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.6bn | at 2018-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2020-09-30d | Cons. | Net assets |
| Net assets / equity | ¥3.4bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.8bn | at 2018-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.7bn | at 2020-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.8bn | at 2018-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥853m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.4bn | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥930m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥374m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥344m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥423m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥345m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥469m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥139m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥114m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥7m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥15m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.1bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥648m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥37.62 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.07 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.03 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.04 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.46 | 2017-10-01 → 2018-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥35.78 | 2021-10-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.25 | 2020-10-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥32.67 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥19.83 | 2018-10-01 → 2019-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥11.26 | 2017-10-01 → 2018-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥350.71 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥310.47 | at 2021-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥248.8 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥164.05 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥89.07 | at 2018-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 81.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.0% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.8% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.7% | at 2018-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.4% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2020-10-01 → 2021-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.9% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.2% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.8% | 2017-10-01 → 2018-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 373 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 272 | at 2021-09-30 | Cons. | Number of employees |
| Employees | 225 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 136 | at 2019-09-30d | Cons. | Number of employees |
| Employees | 96 | at 2018-09-30d | Cons. | Number of employees |
| Revenue | ¥4.7bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥4.4bn | 2020-10-01 → 2021-09-30 | Standalone | Net sales |
| Revenue | ¥3.2bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2017-10-01 → 2018-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥853m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥1.4bn | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥878m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥805m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥453m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥370m | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥888m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.5bn | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | ¥648m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥579m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥304m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥304m | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.7bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥7.1bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥6.0bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.5bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.2bn | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥837m | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥933m | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥6.9bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥6.1bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥3.1bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.5bn | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.0bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.6bn | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥30.03 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥49.7 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.92 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.18 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.9 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.56 | 2021-10-01 → 2022-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.54 | 2020-10-01 → 2021-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.04 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥15.25 | 2018-10-01 → 2019-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥16.62 | 2017-10-01 → 2018-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥317.15 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥284.02 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥232.58 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥153.58 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥82.78 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 89.0% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.7% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.1% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.6% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.5% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.0% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.4% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.3% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 25.8% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 21,622,580 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,574,190 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,473,100 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 19,762,900 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,193,050 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 203 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 151 | at 2021-09-30 | Standalone | Number of employees |
| Employees | 116 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 92 | at 2019-09-30d | Standalone | Number of employees |
| Employees | 66 | at 2018-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 56
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-10-01 → 2022-09-30 | ¥63m |
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | ¥58m |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-09-30 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-09-30 | −¥18m |
| Reconciling Itemsreconciling | segment assets | at 2022-09-30 | ¥7.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥672m |
| Doctor Platformreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥58m |
| Doctor Platformreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥59m |
| Doctor Platformreportable segment | employees | at 2022-09-30 | 236 pure |
| Doctor Platformreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥6.4bn |
| Doctor Platformreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥6.4bn |
| Doctor Platformreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥9m |
| Doctor Platformreportable segment | segment assets | at 2022-09-30 | ¥1.9bn |
| Doctor Platformreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥1.6bn |
| Healthcare Solutionreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥37m |
| Healthcare Solutionreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥21m |
| Healthcare Solutionreportable segment | employees | at 2022-09-30 | 91 pure |
| Healthcare Solutionreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥2.0bn |
| Healthcare Solutionreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥2.0bn |
| Healthcare Solutionreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥9m |
| Healthcare Solutionreportable segment | segment assets | at 2022-09-30 | ¥400m |
| Healthcare Solutionreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥126m |
| —segment total | capex | 2021-10-01 → 2022-09-30 | ¥95m |
| —segment total | depreciation | 2021-10-01 → 2022-09-30 | ¥80m |
| —segment total | revenue | 2021-10-01 → 2022-09-30 | ¥8.5bn |
| —segment total | revenue external | 2021-10-01 → 2022-09-30 | ¥8.5bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥18m |
| —segment total | segment assets | at 2022-09-30 | ¥2.3bn |
| —segment total | segment profit | 2021-10-01 → 2022-09-30 | ¥1.7bn |
| Reconciling Itemsreconciling | capex | 2020-10-01 → 2021-09-30 | ¥107m |
| Reconciling Itemsreconciling | depreciation | 2020-10-01 → 2021-09-30 | ¥60m |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-09-30 | −¥7m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-09-30 | −¥7m |
| Reconciling Itemsreconciling | segment assets | at 2021-09-30 | ¥6.5bn |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-09-30 | −¥474m |
| Doctor Platformreportable segment | capex | 2020-10-01 → 2021-09-30 | ¥61m |
| Doctor Platformreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥53m |
| Doctor Platformreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥5.8bn |
| Doctor Platformreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥5.8bn |
| Doctor Platformreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥7m |
| Doctor Platformreportable segment | segment assets | at 2021-09-30 | ¥1.7bn |
| Doctor Platformreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥2.0bn |
| Healthcare Solutionreportable segment | capex | 2020-10-01 → 2021-09-30 | ¥78m |
| Healthcare Solutionreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥19m |
| Healthcare Solutionreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥1.7bn |
| Healthcare Solutionreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥1.7bn |
| Healthcare Solutionreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥489,000 |
| Healthcare Solutionreportable segment | segment assets | at 2021-09-30 | ¥373m |
| Healthcare Solutionreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥289m |
| —segment total | capex | 2020-10-01 → 2021-09-30 | ¥139m |
| —segment total | depreciation | 2020-10-01 → 2021-09-30 | ¥72m |
| —segment total | revenue | 2020-10-01 → 2021-09-30 | ¥7.4bn |
| —segment total | revenue external | 2020-10-01 → 2021-09-30 | ¥7.4bn |
| —segment total | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥7m |
| —segment total | segment assets | at 2021-09-30 | ¥2.0bn |
| —segment total | segment profit | 2020-10-01 → 2021-09-30 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,332
| Item | Context | Value | Unit |
|---|---|---|---|
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.111 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.027 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.090 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.146 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.002 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.624 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 5194110 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.2402 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 1740900 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.0805 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 1250000 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0578 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 900000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0416 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 700000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0324 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 566500 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0262 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 551200 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0255 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 316900 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0147 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 241300 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0112 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 210913 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0098 | |
| Number of shares held | CurrentYearInstant | 11671823 | |
| Shareholding ratio | CurrentYearInstant | 0.5398 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1300 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21589600 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 215896 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 31680 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 21622580 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 215896 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 1300 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 1300 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0001 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 1300 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 1300 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0001 | |
| Number of male directors and other officers | FilingDateInstant | 8 | |
| Number of female directors and other officers | FilingDateInstant | 1 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.111 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E30650-000IwamiYoMember | 5194110 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |